Sensus Healthcare (SRTS) Earnings Analysis

Sensus Healthcare (SRTS) next reports earnings on 2026-08-06, consensus EPS -0.125 USD. Last quarter (2026-05-07) it missed with EPS -0.16 USD vs -0.125 USD est (-28%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -6.45.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SRTS next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-0.125 USD
Revenue estimate0.00B

SRTS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-0.16 USD-0.125 USD-28%Miss
2026-02-12-0.19 USD-0.055 USD-245.5%Miss
2025-11-06-0.06 USD-0.11 USD+45.5%Beat
2025-08-07-0.06 USD0.01 USD-700%Miss
2025-05-15-0.16 USD0.04 USD-500%Miss
2025-02-050.09 USD0.1 USD-10%Miss
2024-11-140.07 USD0.00778 USD+799.7%Beat

Beat rate: 2/7 (29%) over reported quarters with consensus data.

SRTS valuation and analyst view

Trailing P/E-6.45
Trailing EPS-0.47216 USD
Price / book1.10
Dividend yield0.00%
Market cap0.05B
Analyst consensusBuy (6 buy / 3 hold / 0 sell)
Avg price target6.5 USD

Related research pages

Frequently asked questions

When is Sensus Healthcare (SRTS)'s next earnings date?

Sensus Healthcare is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.125 USD and revenue estimate of 0.00B.

Did SRTS beat earnings last quarter?

In its 2026-05-07 report, SRTS posted EPS of -0.16 USD versus a -0.125 USD estimate — a miss of 28%.

What is SRTS's earnings track record?

Over the last 7 reported quarters with consensus data, SRTS beat estimates 2 times (29%).

What is SRTS's current P/E ratio and EPS?

SRTS trades at a trailing P/E of -6.45 on trailing EPS of -0.47215962093108566 USD.

What do analysts rate SRTS?

Analyst consensus is "Buy" across 9 ratings (0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 6.5 USD.